Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline?

investors.com/news/technology/biogen-stock-biogen-earnings-leqembi-skyclarys-q1-2023

Two of Biogen's newest drugs walloped first-quarter sales expectations on Wednesday, and could help Biogen stock reverse a recent downtrend.
The post Two Notable Biogen Drugs Walloped Sales Forecasts. Will It Be Enough To Reverse Biogen Stock's Decline? appeared first on Investor's Business Daily.

This story appeared on investors.com, 2024-04-24.
The Entire Business World on a Single Page. Free to Use →